Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities

Cancer - United States
doi 10.1002/cncr.24661
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Secondary Philadelphia Chromosome Acquired During Therapy of Acute Leukemia and Myelodysplastic Syndrome

Modern Pathology
Forensic MedicinePathology
2018English

Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2005English

A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2014English

Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia

Acta Haematologica Polonica
OncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy